SOCIETE DE THERAPEUTIQUE MAROCAINE S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 980.2 MAD | -2.95% |
|
-3.90% | +3.07% |
| Sales 2023 | - | Sales 2024 * | - | Capitalization | 7.07B 71.23B |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | - |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 |
26.1
x | P/E ratio 2024 * |
21.3
x | Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 10.68% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | -2.95% | ||
| 1 week | -3.90% | ||
| Current month | -3.43% | ||
| 1 month | -3.43% | ||
| 3 months | -2.95% | ||
| 6 months | -6.65% | ||
| Current year | +3.07% |
1 week
980.10
1 010.00
1 month
923.001 050.00
Current year
923.001 065.00
1 year
923.001 299.00
3 years
900.001 750.00
5 years
375.001 750.00
10 years
278.751 750.00
| Managers | Title | Age | Since |
|---|---|---|---|
Lamia Tazi
CEO | Chief Executive Officer | 47 | 97-10-05 |
Adnane Hilal
DFI | Director of Finance/CFO | - | - |
Mehdi Zaghloul
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mohamed Tazi
BRD | Director/Board Member | - | - |
Bahia Berrada
BRD | Director/Board Member | - | - |
| Director/Board Member | - | 07-06-06 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 982 | +0.18% | 504 |
| 24-04-30 | 980.2 | -2.95% | 11 |
| 24-04-29 | 1,010 | -.--% | 12 |
| 24-04-26 | 1,010 | -.--% | 783 |
| 24-04-25 | 1,010 | -.--% | 1 |
End-of-day quote Casablanca S.E., April 29, 2024
More quotes
Sothema (Société de Thérapeutique Marocaine) is No. 1 in Morocco of manufacturing and marketing licensed pharmaceutical products and biotechnology drugs. The group's activity is organized around 3 areas:
- drug sales: products made under license and under own names;
- importing and sales of drugs, dental products, and ophthalmic equipment;
- subcontractor fabrication of pharmaceutical products: services provided to Moroccan and foreign laboratories.
At the end of 2019, Sothema had 6 production units located in Morocco.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
982
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +3.07% | 701M | |
| +29.68% | 681B | |
| +20.24% | 556B | |
| -4.35% | 361B | |
| +17.65% | 325B | |
| +3.77% | 285B | |
| +14.30% | 235B | |
| +4.31% | 199B | |
| -11.78% | 189B | |
| -3.79% | 157B |
- Stock Market
- Equities
- SOT Stock
